BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2391704)

  • 21. Mutagenicity of nitracrine analogues in Salmonella typhimurium: mutational specificity and activation by bacterial enzymes and rat-liver S9.
    Ferguson LR; Turner PM; Denny WA
    Mutat Res; 1987 Jan; 187(1):1-9. PubMed ID: 3540655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenic and clastogenic activity of nitracrine analogues in cultured V79 Chinese hamster cells.
    Ferguson LR; van Zijl P
    Mutat Res; 1988 Apr; 204(4):655-63. PubMed ID: 3352647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiol-dependent inhibition of RNA synthesis in vitro by acridines: structure-inhibition relationships.
    Gniazdowski M; Szmigiero L; Wilmańska D
    Cancer Lett; 1982 Jan; 15(1):73-9. PubMed ID: 6174208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystallographic and molecular mechanics calculations on the anti-tumor drugs N-[(2-dimethylamino)ethyl]-and N-[(2-dimethyl-amino)butyl]-9-aminoacridine-4-carboxamides and their dications: implications for models of DNA-binding.
    Hudson BD; Kuroda R; Denny WA; Neidle S
    J Biomol Struct Dyn; 1987 Aug; 5(1):145-58. PubMed ID: 3271463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity and the effect of combined treatment with X-rays of an anticancer 1-nitro-9-aminoacridine derivative in L5178Y-R and L5178Y-S cells.
    Szumiel I; Walicka M
    Neoplasma; 1980; 27(6):697-702. PubMed ID: 7254425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective toxicity of nitracrine to hypoxic mammalian cells.
    Wilson WR; Denny WA; Twigden SJ; Baguley BC; Probert JC
    Br J Cancer; 1984 Feb; 49(2):215-23. PubMed ID: 6696822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complexes of nitracrine with DNA. Stoichiometry of binding.
    Szmigiero L; Gniazdowski M
    Arzneimittelforschung; 1981; 31(11):1875-7. PubMed ID: 7198467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antitumor properties of nitracrine and amsacrine analogs.
    Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
    Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenic activity of some 9-aminoalkyl acridine derivatives on S. typhimurium.
    Kalinowska E; Chorazy M
    Mutat Res; 1980 May; 78(1):7-15. PubMed ID: 6991931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
    J Med Chem; 1987 Apr; 30(4):664-9. PubMed ID: 3560161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cells.
    Pawlak JW; Pawlak K; Konopa J
    Chem Biol Interact; 1983 Feb; 43(2):151-73. PubMed ID: 6402314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of some nitro-derivatives of substituted 9-aminoacridine with DNA.
    Filipski J; Marczyński B; Sadzińska L; Chalupka G; Chorazy M
    Biochim Biophys Acta; 1977 Sep; 478(1):33-43. PubMed ID: 196646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tautomeric equilibrium in nitro-9[(alkylamino)amino]acridines: the role of metal ions and hydrogen bond acceptors.
    Maresca L
    Oftalmologia; 2003; 57(2):89-92. PubMed ID: 12974038
    [No Abstract]   [Full Text] [Related]  

  • 34. 32P-post-labelling analysis of DNA adducts formed by antitumor 1-nitro-9-aminoacridines with DNA of HeLa S3 cells.
    Bartoszek A; Konopa J
    Biochem Pharmacol; 1987 Dec; 36(23):4169-71. PubMed ID: 3689442
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationships between DNA-binding kinetics and biological activity for the 9-aminoacridine-4-carboxamide class of antitumor agents.
    Wakelin LP; Atwell GJ; Rewcastle GW; Denny WA
    J Med Chem; 1987 May; 30(5):855-61. PubMed ID: 3572974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intercalating and groove-binding ligands on formation of covalent complexes between nitracrine (Ledakrin, C-283) or 8-methoxypsoralen and DNA.
    Wilmańska D; Małagocka E; Szmigiero L; Gniazdowski M
    Biochim Biophys Acta; 1984 Jul; 782(3):285-94. PubMed ID: 6733111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterodimeric molecules including nucleic acid bases and 9-aminoacridine. Spectroscopic studies, conformations, and interactions with DNA.
    Constant JF; Laûgaa P; Roques BP; Lhomme J
    Biochemistry; 1988 May; 27(11):3997-4003. PubMed ID: 3415969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome aberrations induced by 9-aminoacridine derivatives.
    Michalska J
    Mutat Res; 1986 Jun; 170(3):119-23. PubMed ID: 3713722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA binding, cytotoxicity and inhibitory effect on RNA synthesis of two new 1-nitro-9-aminoacridine dimers.
    Markovits J; Wilmańska D; Lescot E; Studzian K; Szmigiero L; Gniazdowski M
    Chem Biol Interact; 1989; 70(1-2):73-87. PubMed ID: 2472225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.